Study for IFE4PrEP Intervention on PrEP Uptake by Southern African American Women (IFE4PrEP)

IGHID 12113 - Formative Study for I'm Fully Empowered4PrEP Intervention on HIV PrEP Uptake by Southern African American Women (IFE4PrEP Formative Study)

Purpose: This study is partnering with communities to identify the best ways to provide HIV prevention communication and services for women living in public housing who have been disproportionately affected by HIV but underserved by current HIV prevention programs. The investigators want to work with community members to develop and design the delivery of a program to promote awareness of and access to pre-exposure prophylaxis (PrEP) for HIV prevention among women living in public housing.

Participants: Up to 248 cisgender females who are 18 years of age or older and currently reside in Durham Housing Authority (DHA) housing will be enrolled in this study at UNC.

Procedures (methods): Data collection for this formative study will consist of 4 focus groups of up to 12 women in each focus group living in DHA as well as a survey of 200 women living in DHA.

Study Overview

Detailed Description

Study Design

This observational formative study consists of cross-sectional data collection with women living in DHA (Durham Housing Authority) housing through surveys and focus group discussions. Both modes of data collection will service to collect descriptive information to refine the intervention. The survey will also include a randomized messaging experiment (see Data Collection Procedures description below).

Study Duration, Enrollment and Number of Subjects

This formative study will last up to one year (12 months). The investigators will enroll up to 248 participants (up to 200 survey participants and up to 48 focus group participants with some women participating in both) as recruitment allows and as necessitated by thematic saturation.

Study Population

The target population for this study is African American cisgender women at least 18 years old residing in DHA community housing. The vast majority of DHA residents are African American, so the investigators anticipate recruiting participants who are majority African American without explicitly excluding prospective participants on the basis of race. Women will be eligible to participate if they meet the following criteria:

  1. 18 years of age or older
  2. Identify as cisgender female (assigned female sex at birth and currently identify as female)
  3. Currently reside in Durham Housing Authority (DHA) housing

Data Collection Procedures

Survey

The self-administered electronic survey will assess the topics listed below and will include a randomized messaging experiment to assess the effect of exposure messaging about PrEP with variable framing on attitudes and perceived norms about PrEP. Participants will complete the survey as follows:

  • Women recruited through community network referral may complete the survey on their own device at the time of their choosing.
  • Women recruited through community/public events or FGDs will be provided the option to either: a) complete the self-administered electronic survey during the event on a study-owned device (if an in-person event). Limited literacy, vision-impaired, or any participant who desires assistance may request that a study staff member read the questions aloud to them for them to complete the survey, or request to complete the survey as an interviewer-administered survey in a private location; or b) complete the survey at a time of their choosing on their own device.

Survey topics will include:

  • Sociodemographic characteristics (age, race/ethnicity, DHA community of residence)
  • PrEP awareness & knowledge
  • Attitudes toward PrEP
  • Randomized messaging experiment (see below)
  • Perceived PrEP norms
  • Perceived ability to access PrEP
  • Barriers and facilitators to using PrEP
  • Perceived HIV risk
  • HIV risk factors/behaviors
  • Likelihood to use PrEP/interest/willingness to use PrEP
  • Perceived stigmas

The survey will include an embedded randomized 2 x 2 between-subjects experiment (gain vs. loss framing by intrinsic vs. extrinsic motivation messaging) evaluating the effects of the alternative messaging approaches on intermediate endpoints in Table 3 of the protocol to identify the approaches most associated with positive PrEP attitudes and norms. The experiment will be embedded in a questionnaire administered before focus group sessions to 40 focus group participants and to 160 additional women in study communities (total of 200, 50 per community). During each of the 4 focus groups, the investigators also will explore women's reactions to alternative modes (e.g., flyers, posters, apps, social media) of PrEP messaging.

Hypotheses for each messaging attribute are as follows:

H1: Gain framing will be associated with more positive attitudes and more positive perceived norms about PrEP than loss framing.

  • Gain framing: PrEP puts me in control
  • Loss framing: Without PrEP, I'm less in control

H2: Demographic targeting will be associated with more positive attitudes and more positive perceived norms about PrEP than non-demographically targeted messaging.

  • Demographically targeted: [Image of African American woman]
  • Extrinsic framing: [Image of women of multiple races]

Focus Group Discussions (FGDs)

Focus Group participants will be given the option to participate in a focus group by Zoom or in person. Per North Carolina Executive Orders current at the time of data collection, the investigators anticipate that in-person FGDs will be conducted in a private indoor location with sufficient ventilation, 6-foot distancing between participants, and with face masks for both FGD facilitators and participants. Focus groups with limited participants showing up may be converted to individual in-depth interviews. With participant consent, FGDs will be audio-recorded for analysis. Zoom focus groups will be video/audio-recorded with the video deleted and the audio retained directly following the FGD. Focus groups will be led by trained study staff members who will facilitate a discussion on the topics below:

  • Current awareness & knowledge of PrEP (including current sources of information about PrEP)
  • Attitudes toward PrEP (including any stigmas about PrEP, perceived risk)
  • Perceptions of and recommendations for messaging about PrEP use among cisgender women (open-ended then specific reactions)
  • Perceptions of and recommendations for messaging about PrEP mobile unit (open-ended then specific reactions)
  • Preferences for mobile PrEP unit delivery features (e.g., timing, location, appointment type, delivery of complementary services).
  • Best media/modes for providing messages about PrEP and the mobile unit to women in DHA.
  • Perceptions of peer networkers, best approach for contacting residents and providing information.
  • Barriers and facilitators to using PrEP

Study Type

Observational

Enrollment (Actual)

31

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • North Carolina
      • Chapel Hill, North Carolina, United States, 27514
        • University of North Carolina

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The target population for this study is African American cisgender women at least 18 years old residing in DHA (Durham Housing Authority) community housing. The vast majority of DHA residents are African American, so the investigators anticipate recruiting participants who are majority African American without explicitly excluding prospective participants on the basis of race.

Description

Inclusion Criteria:

Women will be eligible to participate if they meet the following criteria:

  • 18 years of age or older
  • Identify as cisgender female (assigned female sex at birth and currently identify as female)
  • Currently reside in Durham Housing Authority (DHA) housing

Exclusion Criteria:

Women will not be eligible to participate if they meet the following criteria:

  • Younger than 18 years of age
  • Do not Identify as cisgender female (assigned female sex at birth and currently identify as female)
  • Do not currently reside in Durham Housing Authority (DHA) housing

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Focus Group
There will be 4 focus groups of up to 12 women in each focus group.
Survey Group
There will be up to 200 women who complete the survey for this study.

Gain framing: Participant feels PrEP puts her in control

Participants (majority of whom will be African American) will be shown an image of women of multiple races.

Loss framing: Without PrEP, participant feels less in control

Participants (majority of whom will be African American) will be shown an image of women of multiple races.

Gain framing: Participant feels PrEP puts her in control

Participants (majority of whom will be African American) will be shown an image of an African American woman.

Loss framing: Without PrEP, participant feels less in control

Participants (majority of whom will be African American) will be shown an image of an African American woman.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Modified Jaspal, Lopes, and Maatouk Attitudes toward PrEP Scale (APS)
Time Frame: Baseline
A subset of the Attitudes toward PrEP Scale (APS) will be used to assess the association between message exposure and attitudes toward pre-exposure prophylaxis (PrEP). This sub-set scale will include nine items rated on a 5-point Likert scale (responses ranging from 1=Strongly Disagree to 5=Strongly Agree). The nine items are a sub-set of the original APS scale and will include four items comprising sub-scale 2, three items comprising sub-scale 3, and two items from sub-scale 1. A mean score will be calculated for each complete sub-scale (2 and 3) ranging from 1-5. Each of the two items from sub-scale 1 will be scored individually, ranging from 1-5. Higher scores indicate more positive attitudes toward PrEP.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Carol Golin, MD, UNC-Chapel Hill
  • Principal Investigator: Lauren Hill, PhD, UNC-Chapel Hill

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 18, 2023

Primary Completion (Actual)

November 28, 2023

Study Completion (Actual)

March 10, 2024

Study Registration Dates

First Submitted

October 8, 2021

First Submitted That Met QC Criteria

October 8, 2021

First Posted (Actual)

October 21, 2021

Study Record Updates

Last Update Posted (Estimated)

April 26, 2024

Last Update Submitted That Met QC Criteria

April 24, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on HIV Prevention

3
Subscribe